Rise of the Resistance: Challenging Carbapenem-Resistant Gram-Negative Infections

Hear from experts on strategies to optimize treatment regimens for carbapenem-resistant Enterobacterales, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia based on the latest guidance recommendations, clinical data, and patient-specific and infection-related factors. Reinforce your learning with an on-demand video, downloadable slides, and an expert-authored ClinicalThought commentary.

Share

Program Content

Events

Activities

Treating P. aeruginosa With Difficult to Treat Resistance
Where Are We Now? A Decade of Using Newer β-lactams to Treat Pseudomonas aeruginosa With Difficult-to-Treat Resistance
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: September 25, 2024

Expires: September 24, 2025

Faculty

cover img faculity

Marguerite L. Monogue, PharmD, BCIDP

Infectious Diseases Pharmacy Specialist
Assistant Professor, Division of Internal Medicine
University of Texas Southwestern
Dallas, Texas

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

Supported by an educational grant from Shionogi Pharma, Inc.

Shionogi Pharma, Inc.